AirSeal®: Fact or Fiction

  • Published: 1/22/2025
  • 2 min
FACT
-
OR
-
FICTION
AirSeal® is only for robotic-assisted laparoscopic surgery.
FICTION
AirSeal® is for every minimally invasive surgery in the abdominal and thoracic cavities for both adult and pediatric patients.
FACT
-
OR
-
FICTION
AirSeal® has been used to treat over 7.5 million patients.
FACT
AirSeal® is used in over 4,000 facilities in 80 countries to treat over 7.5 million patients.
FACT
-
OR
-
FICTION
High-flow conventional insufflation provides stability and improves patient outcomes.
FICTION
There is no evidence that suggests high-flow conventional insufflation improves stability or patient outcomes. AirSeal® is the only insufflation system backed by clinical data showing improved patient outcomes at low pressure.
There’s still more to AirSeal® than meets the eye. From its proprietary cannula design to its data-backed improvement of patient outcomes, AirSeal® is changing the insufflation game.

Try AirSeal® in your hospital.

Schedule A Demo

Related Blogs

Partnership Spotlight: MTF

4/7/2025
At CONMED, we’re delighted to offer high quality grafts thanks to our partnership with MTF Biologics. Find out more about MTF and CONMED’s partnership in this blog.

Elite Performance on the Mat & in the OR: The Paradigm® Hip Portfolio

3/24/2025
The NCAA Wrestling Championships may be over, but the precision, strength, and endurance displayed on the mat continue to inspire—just like in another arena where these qualities are essential: the operating room.

From Slam Dunks to Setbacks: How Knee Injuries Impact the NCAA Basketball Tournament

3/18/2025
It's one of the most exhilarating times of the year for basketball fans. High levels of competition comes an increased risk of injuries, particularly to the knees.

The Hidden Cost of Non-Modular Power Systems

3/11/2025
When making power proposals and purchases, it’s important to consider what solution will be right for your hospital - specifically when looking at modular vs non-modular systems.